International Journal of Pharmacology

2005 | 9,241,751 words

The International Journal of Pharmacology (IJP) is a globally peer-reviewed open access journal covering the full spectrum of drug and medicine interactions with biological systems, including chemical, physiological, and behavioral effects across areas such as cardiovascular, neuro-, immuno-, and cellular pharmacology. It features research on drug ...

Effect of Milling on Solid State Transformation of Sulfamethoxazole

Author(s):

Erizal
Research Group of Pharmaceutics, School of Pharmacy, Institut Teknologi Bandung, Indonesia
S. Yeyet Cahyati
Research Group of Pharmaceutics, School of Pharmacy, Institut Teknologi Bandung, Indonesia
S. Sundani Nurono
Research Group of Pharmaceutics, School of Pharmacy, Institut Teknologi Bandung, Indonesia
Auzal Halim
Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Andalas University, Indonesia


Read the Summary


Year: 2008 | Doi: 10.3923/ijp.2008.140.144

Copyright (license): Creative Commons Attribution 4.0 International (CC BY 4.0) license.


[[[ p. 1 (unverified proofreading) ]]]

[Find the meaning and references behind the names: Life, Data]

Life International Journal of Pharmacology ISSN 1811-7775 Life science alert ansinet Asian Network for Scientific Information

[[[ p. 2 (unverified proofreading) ]]]

[Summary: This page introduces a study on the effect of milling on sulfamethoxazole's solid state. It details the materials, milling process, and characterization techniques like SEM, XRD, FT-IR, and DSC. The study found milling didn't cause polymorphic transformation or amorphization, but created crystal defects and reduced particle size.]

[Find the meaning and references behind the names: Crowley, Step, Natural, Creation, Change, Halim, Class, India, Aim, Chieng, Raw, Key, Nakai, Morris, Block, Lab, Development, Time, Head, Ability, Size, Brittain, Rise, State, Acid, Ray, Place, Hle, Last, Red, Grant, Bond, Due, Crystal, Guillory, Author, Study, Min, Sem, Lin, Small, Yang]

International Journal of Pharmacology 4 (2): 140-144. 2008 ISSN 1811-7775 2008 Asian Network for Scientific Information Effect of Milling on Solid State Transformation of Sulfamethoxazole ***Erizal, ¹S. Yeyet Cahyati, S. Sundani Nurono and 'Auzal Halim 'Research Group of Pharmaceutics, School of Pharmacy, Institut Teknologi Bandung, Indonesia *Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Andalas University, Indonesia Abstract: The purpose of this research was to investigate the influence of milling process on solid state transformation of sulfamethoxazole. Raw material Sulfamethoxazole was obtained from Virchow Lab. India. Milling was carried out by using Retsch Mühle with definite rate and pressure, for 10, 20 and 30 min. The milled samples were characterized by scanning electron microscope, powder X-ray diffraction, Fourier transform Infra Red Spectroscopy and thermal analysis DSC. Raw material sulfamethoxazole was found to be a form 1. According to SEM analysis, powder X-ray diffraction pattern, FT-IR analysis and thermal analysis, Milling process of form 1 sulfamethoxazole with various milling time didn't caused polymorphic transformation and amorphisation. But the milling can created defect on crystal lattice of sulfamethoxazole form 1. Milling process also reduced the particle size of sulfamethoxazole form 1, but not its crystallinity. The result of this research demonstrates that milling process can produced defect on crystalline solid of sulfamethoxazole form 1. Key words: Sulfamethoxazole, milling, crystal defect INTRODUCTION The effects of pharmaceutical processing on the crystalline state of drug polymorphs and solvates have been discussed recently by Brittain and Fiese (1999). The stresses applied to crystals during pharmaceutical processing can cause defects in their crystal lattices and contribute to lattice disorder, thus affecting the physical properties of the resulting powder (Morris et al., 2001). Milling is a key process in the preparation of many solid dosage forms, particularly in the last processing step in the production of bulk drug substance to reduce particle size, is often accompanied by a decrease in crystallinity due to the creation of lattice defects. beginning at the surface. The defects created by mechanical activation of the solid on the surface can migrate, transform and change their number and nature. If the defects in the mechanically activated crystal head to produce a crystal lattice different from the initial lattice, then a polymorphic transformation has taken place (Vippagunta et al., 2001; Brittain, 2002). Milling induced polymorphic changes have been observed for many small drug molecules, such as ramitidine hydrochloride, famotidine and indomethacin (Chieng et al., 2006; Lin et al., 2006, Crowley and Zografi, 2002). Sulfamethoxazole (SMZ), one of the sulfonamides is a class of drugs whose molecular structures contain the sulfanilamide moiety or a sulfanilamide analog. The structural resemblance between the sulfanilamide the grouping and p-aminobenzoic acid enables sulfanilamides to block folic acid synthesis in bacteria, which accounts for the antibacterial (bacteriostatic) action of these drugs. Sulfonamides exhibit interesting solidstate properties, among which is the ability for many of these drugs to exist in two or more polymorphic forms (Adsmond and Grant, 2001). Pharmaceutical solid polymorphism is defined as the ability of a drug compound to crystallize into more than one different crystalline forms, which the molecule have different packing arrangement and/or conformations within the crystal lattice (Byrn et al., 1995). Different crystalline polymorph can significantly influence the physicochemical properties, formulation development. and manufacturing production of drug, resulting in the problems of compatibility, dissolution bioavailibility. bioactivity and shelf-life of drug substance (Newmann and Vuti, 2003). The solid-state properties of sulfonamides have been studied by Yang and Guillory (1972), who postulated that the propensity for hydrogen bonding in the solid state, due to the presence of various hydrogen-bond donors and acceptors, can give rise to polymorphism. Crystal forms of Sulfamethoxazole are known to exist in three polymorphic fom 1, 2 and 3 (hemihydrate) (Takasuka and Nakai, 2001). The aim of this research was to study the effect of milling process on solid state transformation sulfamethoxazole using Retsch Mühle as a function of Corresponding Author: Erizal, Research Group of Pharmaceutics, School of Pharmacy, Institut Teknologi Bandung, Indonesia 140

[[[ p. 3 (unverified proofreading) ]]]

[Summary: This page describes the materials and methods used in the study, including sample preparation, milling procedures, and the specific instruments used for SEM, XRD, DSC, and FT-IR analysis. It also presents initial results showing the raw sulfamethoxazole material is form 1 based on DSC thermogram.]

[Find the meaning and references behind the names: Range, Double, Lipi, Deg, Seiko, Fig, Pellet, Gas, Int, Single, Aluminium, Prior, Tokyo, September, Under, Philips, Sharp, Sly, Habit, Point, Holland, Sec, Pin, November, Temp, Sample, Batch, Centre, Cuka, Tape, Peak]

Int. J. Pharmacol., 4 (2): 140-144, 2008 milling time. Scanning electron microscopy, powder X-ray diffraction, differential scanning calorimetry and Fourier transform infrared (FT-IR) spectroscopy were used to characterize the milled samples al milling times between 10 and 30 min. MATERIALS AND METHODS This sly was performed in September-November 2007. Preparation of milled samples, FT-IR spectroscopic analysis and powder X-ray analysis was conducted in ITB Bandung Indonesia. Scanning electron microscope analysis was done in the centre research of geology Bandung Indonesia. While Thermal analysis DSC was conducted in the centre research of physics LIPI Bandung Indonesia. Sulfamethoxazole was kindly obtained from P.T Pyridam (Imported from Virchow Lab. India, batch. No. 091 50307), the KBr crystal for the pellets. Preparation of milled samples: A certain amount of sulfamethoxazole was respectively milled for different times 10, 20 and 30 min by Reisch Mühle apparatus. It was adjusted with definite rate and pressure. Scanning electron microscopy: Electron-micrographs of crystal habit of unmilled and milled particles was examined using SEM (JEOL model JSM-6360LA, Tokyo, Japan). The specimen were mounted on a metal stub with double. sided adhesive tape and coated under vacuum with goldpaladium (Au 80% and Pd 20%) prior to observation. The particles size of crystals was estimated from electron micrographs. Powder X-ray diffraction: The XRD patterns of solidstate forms of sulfamethoxazole and the milled samples were measured using Philips PW 1710 diffractometer (Philips, Holland). Radiation generated from Cuka source. Current of 30 mA and generator voltage of 10 kV were used for the study. The instrument was operated over the 20 range 5-40 with a step size of 0.01, time per step of 0.5 sec and receiving slit of 0.2 mm. Differential scanning calorimetry: DSC analysis of approximately 6.5 mg samples in pin-holed aluminium crimped pans was performed using Seiko Instrument Inc. DSC (Japan), at heating rate of 10°C per min over a temperature range 30-200 C. Samples were purged with nitrogen gas at 60 mL min throughout the analysis. Fourier transform infrared (FT-IR) spectroscopy: The infrared spectra of the samples were obtained using KBr pellet using a FT-IR spectrophotometer (Jasco model FT-IR-4200 type A), over a range of 400-4000 cm¯¯ RESULTS AND DISCUSSION Before milling process was performed on powder sample of sulfamethoxazole, il was characterized the crystal form by spectroscopy IR, thermal and powder X-ray diffraction analysis. It has been reported that crystal form of Sulfamethoxazole had three polymorphic form 1, 2 and 3 (hemihydrate), in which form 1 was the most stable form (Takasuka and Nakai, 2001; Yang and Guillory, 1972). Figure 1a shows DSC thermogram of raw material SMZ, it was observed single sharp endothermic peak at 172.7°C (melting point of SMZ). This endothermic peak was specific for polymorf 1 of SMZ. FT-IR Spectra of DSC (MW) DSC (mW) -3- -11- -19- (a) -27 30 72.5 -11- -19- (b) SMZ 115 146.1mJ mg 172.7°C 157.5 200 Temp. °C (Heating) 149.5 mJ ng Milled SMZ 172,6°C -27- 30 725 115 Temp. °C (Ileating) 157.5 200 Fig. 1 DSC thermogram of (a) Unmilled SMZ and (b) milled SMZ after 30 min 141

[[[ p. 4 (unverified proofreading) ]]]

[Summary: This page elaborates on the results and discussion, confirming the raw material is sulfamethoxazole form 1. It discusses the effect of milling on particle size, crystal habit, and enthalpy values, indicating crystal defects. SEM images show particle size reduction and surface defects after milling.]

[Find the meaning and references behind the names: Present, Heng, Plate, Still, Zek]

Int J Pharmacol., 4 (2): 140-144, 2008 SMZ also supported thermal analysis (Fig. 2), several characteristic absorption bands at 3300 dan 3150 cm¯ were observed that attributed to the amide N-H stretching vibration for form 1. Both data of this study were consistent with the report of previous studies. The raw material of sulfamethoxazole used in this study was proved to be a form 1. In preparing pharmaceutical solid dosage form, milling process is generally used for reducing the particle size of a solid drug to increase its dissolution rate, particularly for water insoluble drug. Many papers have 16 10 4000 3000 I 2000 Warenumber (cm) 1000 400 Fig. 2: FT-IR spectra of raw material of sulfamethoxazole reported about the effect of milling on the physical and chemical properties of drugs (Lin et al., 2006; Heng et al., 2006). In the present study, the sulfamethoxazole form 1 was milled for variously of time. The changes in habit crystal DSC thermogram, X-ray diffraction pattem and FT-IR spectra of sulfamethoxazole form 1 were determined. Upon milling, sulfamethoxazole form 1 showed a single endothermic event of melting (Fig. 1) with no significant difference in melting point between the milled and unmilled powder of SMZ. The milling process only changes in enthalpy values in milled (143.5 mJ mg) and unmilled SMZ (146.1 mJ mg) indicated occurrence of crystal defects during milling (Chikhalia et al., 2006). The effect of milling on electron-micrographs of crystal habit of sulfamethoxazole is shown in Fig 3. It showed plate like habit crystal of sulfamethoxazole form 1 was obtained from supplier. From the SEM images for the milled sample, Fig. 3b and d, it could be seen that particle size reduction was taken place and defect on surface of crystal was observed. However if SEM images was magnified until 10.000x (Fig 3), it can still found the habit crystal of microcrystalline of sulfamethoxazole form 1 The mechanical processing can produce defect in crystalline solids has been known for sometime and it is equally established that defects can influence powder Zek 50001 1E/OCT/67 zekua 098 Im 988) 16/OCT/87) Fig 3: Scanning electron micrographs of sulfamethoxazole powder (a) unmilled sample magnifications 500x, (b) milled 30 min magnifications 500x, () unmilled sample magnifications 3.500x and (d) milled sample 30 min magnifications 10.000x 142

[[[ p. 5 (unverified proofreading) ]]]

[Summary: This page continues the results and discussion, analyzing powder X-ray diffraction patterns and FT-IR spectra of milled samples. It concludes that milling doesn't introduce different phases but modifies crystal habit and causes crystal defects, as evidenced by changes in peak intensities in XRD patterns.]

[Find the meaning and references behind the names: Zhang, Bala, Twist, New, Planes, Long, Sal, Foreign, Missing, Thela, Asas, Take, General, Danh, Line, Edge]

Intensity Int. J. Pharmacol., 4 (2): 140-144, 2008 stmal alslaaa sal alalmas st danh az bala dr asas 10 1.5 20 20 2.5 30 35 10 16 (0) 10 4000 3000 16 15 (b) 10 2000 Wavenumber (cm¹) 1000 400 Fig. 4: The powder X-ray diffraction pattern of sulfamethoxazole (a) umilled sample, (B) milled 10 min, (c) milled 20 min and (d) milled 30 min properties. Point defects can be classified as vacancies (lattice sites from which units are missing), interstitials (molecules that have slipped into voids between lattice sites), or substitutionals (a foreign molecule occupying a lattice site). Additional defects that are encountered in crystals are line defects (ie., edge and SCTCW dislocations), or surface defects (ie. tilt or twist boundaries). The mechanical activation actions of either grinding or compression serve to cause a variety of deformations and fractures in a solid, which is of sufficient magnitude, will serve to destroy the long-range order characteristic of a crystal and leave only the shortrange order of an amorphous material (Brillain 2002). Tritroduction of a polymorphic species during milling is not an uncommon event and is well documented in the literature. Some phase transformation can take several hours to occur (Zhang et al., 2002), while others can occur in minutes (Lin et al., 2006). It is thought that phase changes in the solid state require three steps (Bym et al.. 1999); molecular loosening, solid solution formation and crystalisation of new phase. The powder X-ray diffraction pattern of milled samples from different time of milling are shown in Fig. 4. powder X-ray diffraction is a useful method for determining the presence of amorf and polymorphic or crystal habit modifications in drug crystal. In general, for two form of crystal, when the pattern (ie., peak position) are identical, they have the same internal structures. Whereas if the patterns are different, then the crystal have different internal structures and are polymorphic (Byrn et al., 1999). Here, all the sample exhibited interference with similar peak positions (2 theta values). Therefore, the presence of different phase in milled SMZ. was ruled out. However the relative intensities of their H 4000 3000 14 (c) 12 10 2000 Wavenumber (cm) 2000 1000 400 1000 3000 1000 100 Wavenumber (an¯) 17 (d) 15 10 1000 3000 2000 1000 100 Wavenumber (em-') Fig. 5: FT-IR spectra of sulfamethoxazole (a) omilled sample, (b) milled 10 min, (c) milled 20 min and (d) milled 30 min interference peak XRD) were modified. Peak intensities at 2 thela 20.6° and 21.5° as shown on Fig. 4 changed during milling. This was attributed to the markedly different. crystal habit and crystal defect of the samples. Therefore, the relative abundance of the planes exposed to the X-ray would have been altered, producing the variations in the relative intensities of the interference peaks or this may be due to differences in the crystal sizes. As presented in Fig. 5, the principal absorption bands in the infrared spectra of urmilled and milled of sulfamethoxazole form 1 were similar, suggesting there 143

[[[ p. 6 (unverified proofreading) ]]]

[Summary: This page concludes that milling does not transform the solid state phase of sulfamethoxazole form 1, but causes crystal defects, changes particle size, and crystal habit. It includes a list of references used in the study.]

[Find the meaning and references behind the names: Williams, Gran, Pharm, Zell, Marcel, Dekker, Wang, Active, Eckhard, Adv, Sci, York, Forbes, Pfeiffer, West, Ill, Raman, Energy, Burkhardt, Saville, Dev, Stowell, Munson, Mill, Able, Storey, Cheng]

Int. J. Pharmacol., 4 (2): 140-144, 2008 were no differences between the internal structure and conformation of these samples. The infrared spectrum is extremely sensitive to structure and conformation of a compound and thus can be used to compare the structure of a compound in different solid states (Brittain, 1997). CONCLUSION Mechanical energy by milling process during 30 min were not able to transform solid state phase of sulfamethoxazole form 1. The milling only caused crystal defect on lalice and changes on particle size and crystal habit. REFERENCES Adsmond, D.A. and D.J.W. Grant, 2001. Hydrogen bonding In sulfonamides. J. Pharm Sci. 90 (12): 2058-2077. Brillain, H.G., 1997. Spectral methods FOT The characterization of polymorphs and solvates. J. Pharm. Sci., 86(4): 405-412. Brittain, H.G. and EF. Fiese, 1999. Effects of Pharmaceutical Processing on Drug Polymorphs and Solvates. In: Polymorphism 11 Pharmaceutical Solids, Brittain, H.G. (Ed.). Marcel Dekker, New York, pp: 331-361. Brillain, H.G., 2002. Minireview: Effects of mechanical processing on phase composition. J. Pharm. Sci., 91 (7): 1573-1580. Bym, S., R. Pfeiffer, M. Gancy, C. Hoiberg and G. Poochikian, 1995. Pharmaceuticals solids, a strategic approach to regulatory considerations. Pharm. Res., 12 (7): 915-951. Byrn, S.R., R.R. Pfeiffer and J.G. Stowell, 1999. Solid-State Chemistry of Drugs, SSCT, Inc., West Lafayelle. Chieng, N., Z. Zujovic, G. Bowmaker, T. Rades and D. Saville, 2006. Effect of milling condition on solid state conversion of ranitidine hydrochloride form 1. Int. J. Pharm., 327 (1-2): 36-44. Chikhalia, V., R.T. Forbes, R.A. Storey and M. Ticehurst, 2006. The effect of crystal morphology and mill type on milling induced crystal disorder. Eur. J. Pharm. Sci., 27 (1): 19-26. Crowley, K.J. and G. Zografi, 2002. Cryogenic grinding of indomethacin polymorphs and solvates: Assessment of amorphous phase formation and amorphous phase physical stability. J. Pharm. Sci., 91 (2): 492-507. Heng, J. Y., F. Thielmann and D.R. Williams, 2006. The effects of milling on the surface properties of form I paracetamol crystals. Pharm. Res., 23 (8): 1918-1927. Lin, S.Y., W.T. Cheng and S.L. Wang, 2006. Thermodynamic and Kinetics characterization of polymorphic tansformation of famotidine during grinding. Int. J. Pharm., 318 (1-2): 86-91. Newmann, A.W. and S.R. Byrn, 2003. Solid-state analysis of the active pharmaceutical ingredient in drug product. Drug Disc. Today, 8 (19): 898-905. Morris, K.R., ILL. Griesser, C.J. Eckhard and LG. Stowell. 2001 Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. Adv. Drug Dev. Rev., 48 (1): 91-114. Takasuka, M. and H. Nakai, 2001. IR and raman spectral and X-ray structural studies of polymorphic forms of sulfamethoxazole. Vibr. Spect., 25 (2): 197-204. Vippagunta, S.R., H.G. Brillain and D.J.W. Gran, 2001. Crystalline solids. Adv. Drug Dev. Rev., 18 (1): 3-26. Yang, S.S. and J.K. Guillory, 1972. Polymorphism in sulfonamides. J. Pharm. Sci., 61 (1): 26-40. Zhang, G.Z., C. Gu, M.T. Zell, R.T. Burkhardt and E.J. Munson, 2002. Crystallization and transitions Sulfamerazine polymorphs. J. Pharm. Sci., SI (4): 1089-1099. of 144

Other Health Sciences Concepts:

[back to top]

Discover the significance of concepts within the article: ‘Effect of Milling on Solid State Transformation of Sulfamethoxazole’. Further sources in the context of Health Sciences might help you critically compare this page with similair documents:

Shem, Dissolution, Milling, Grinding, Physical properties, Compression, Internal structure, Pharmaceutical processing, Shelf life, Bioavailability, Bacteriostatic action, Particle size, X-ray diffraction, Solid dosage form, Physicochemical properties, Raw material, XRD pattern, Physical and chemical properties, Scanning Electron Microscopy, Indomethacin, Particle size reduction, Temperature range, Hydrogen bonding, Bioactivity, Fourier transform infrared, Differential scanning calorimetry, Melting point, Infrared spectra, Dissolution rate, Antibacterial action, Dislocation, Formulation Development, X-ray diffraction pattern, Thermal analysis, FT-IR spectroscopy, Ranitidine hydrochloride, Crystalline Form, Fourier transform infrared (FT-IR) spectroscopy, Powder X-ray diffraction, Crystal habit modification, Polymorphic form, DSC thermogram, Crystallinity, Electron microscopy, Crystalline state, Hydrogen bond acceptor, DSC Analysis, Crystal morphology, Powder properties, Famotidine, Relative abundance, Drug molecule, Endothermic peak, Hydrogen bond donor, Drug substance, Mechanical energy, Crystalline solid, Phase transformation, Polymorphic transformation, Water insoluble drug, Electron micrograph, Sulfonamide, Milling process, FT-IR spectrophotometer, Sulfamethoxazole, Phase change, Crystal lattice, Polymorphic species, Fracture, Crystal habit, Absorption band, Peak position, Deformation, Solid state properties, Powder x-ray diffraction analysis, Crystal size, Mechanical processing, Solid state, Particles size, Conformation, Vacancies, Amorphous material, Drug compound, Relative intensities, Solvates, Bulk drug substance, Lattice defects, Mechanical activation, Packing arrangement, Manufacturing production, Solid state transformation, Milling time, Step size, Receiving slit, Heating rate, Nitrogen gas, KBr pellet, Microcrystalline, Surface defects, Solid solution formation, Crystal defect, Interference peak, Crystal form, Thermal analysis DSC, Double sided adhesive tape, Small drug molecule.

Let's grow together!

I humbly request your help to keep doing what I do best: provide the world with unbiased sources, definitions and images. Your donation direclty influences the quality and quantity of knowledge, wisdom and spiritual insight the world is exposed to.

Let's make the world a better place together!

Like what you read? Help to become even better: